Phase I clinical and pharmacokinetic studies of the taxoid derivative RPR 109881A administered as a 1-hour or a 3-hour infusion in patients with advanced solid tumors (Q48511935)
scientific article
Language:
Current Data About Phase I clinical and pharmacokinetic studies of the taxoid derivative RPR 109881A administered as a 1-hour or a 3-hour infusion in patients with advanced solid tumors
(P31) (Q13442814)
(P248)
(P698) 12176795
(P813) Monday, February 12, 2018
(P854) http://europepmc.org/abstract/MED/12176795

(P304) 1140-1150
(P248)
(P698) 12176795
(P813) Monday, February 12, 2018
(P854) http://europepmc.org/abstract/MED/12176795

(P433) 7
(P248)
(P698) 12176795
(P813) Monday, February 12, 2018
(P854) http://europepmc.org/abstract/MED/12176795

(P478) 13
(P248)
(P698) 12176795
(P813) Monday, February 12, 2018
(P854) http://europepmc.org/abstract/MED/12176795

(P577) Monday, July 1, 2002
(P248)
(P698) 12176795
(P813) Monday, February 12, 2018
(P854) http://europepmc.org/abstract/MED/12176795

(P921) (Q323936)
(P887)

(P1433) (Q326122)
(P248)
(P698) 12176795
(P813) Monday, February 12, 2018
(P854) http://europepmc.org/abstract/MED/12176795

(P1476) "Phase I clinical and pharmacokinetic studies of the taxoid derivative RPR 109881A administered as a 1-hour or a 3-hour infusion in patients with advanced solid tumors" (language: en)
(P248)
(P698) 12176795
(P813) Monday, February 12, 2018
(P854) http://europepmc.org/abstract/MED/12176795

(P2093) C Sessa
(P1545) 1
(P248)
(P698) 12176795
(P813) Monday, February 12, 2018
(P854) http://europepmc.org/abstract/MED/12176795

C Cuvier
(P1545) 2
(P248)
(P698) 12176795
(P813) Monday, February 12, 2018
(P854) http://europepmc.org/abstract/MED/12176795

S Caldiera
(P1545) 3
(P248)
(P698) 12176795
(P813) Monday, February 12, 2018
(P854) http://europepmc.org/abstract/MED/12176795

J Bauer
(P1545) 4
(P248)
(P698) 12176795
(P813) Monday, February 12, 2018
(P854) http://europepmc.org/abstract/MED/12176795

S Van Den Bosch
(P1545) 5
(P248)
(P698) 12176795
(P813) Monday, February 12, 2018
(P854) http://europepmc.org/abstract/MED/12176795

C Monnerat
(P1545) 6
(P248)
(P698) 12176795
(P813) Monday, February 12, 2018
(P854) http://europepmc.org/abstract/MED/12176795

D Semiond
(P1545) 7
(P248)
(P698) 12176795
(P813) Monday, February 12, 2018
(P854) http://europepmc.org/abstract/MED/12176795

D Pérard
(P1545) 8
(P248)
(P698) 12176795
(P813) Monday, February 12, 2018
(P854) http://europepmc.org/abstract/MED/12176795

A Lebecq
(P1545) 9
(P248)
(P698) 12176795
(P813) Monday, February 12, 2018
(P854) http://europepmc.org/abstract/MED/12176795

M Besenval
(P1545) 10
(P248)
(P698) 12176795
(P813) Monday, February 12, 2018
(P854) http://europepmc.org/abstract/MED/12176795

M Marty
(P1545) 11
(P248)
(P698) 12176795
(P813) Monday, February 12, 2018
(P854) http://europepmc.org/abstract/MED/12176795

other details
description scientific article

External Links
(P356) 10.1093/ANNONC/MDF174
(P698) 12176795
(P5875) 11210077